-       Report 
- February 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- November 2023
-  71 Pages 
- France 
   From       €3115EUR$3,500USD£2,742GBP 
          -       Report 
- July 2024
-  105 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  185 Pages 
- North America 
   From       €3070EUR$3,450USD£2,702GBP 
           -       Report 
- October 2023
-  146 Pages 
- Africa, Middle East 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- October 2023
-  145 Pages 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- July 2023
-  198 Pages 
- Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- June 2023
-  184 Pages 
- Asia Pacific 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2023
-  185 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- July 2023
-  140 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
            -       Report 
- September 2024
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
      €4316EUR$4,850USD£3,799GBP 
       
      Radiopharmaceutical Theranostics is a field of Nuclear Medicine and Radiopharmacology that focuses on the development of radiopharmaceuticals for the diagnosis and treatment of diseases. Radiopharmaceuticals are drugs that contain radioactive isotopes and are used to diagnose and treat diseases such as cancer, heart disease, and neurological disorders. Theranostics is a combination of the words “therapy” and “diagnostics” and refers to the use of radiopharmaceuticals for both diagnosis and    treatment. Radiopharmaceutical Theranostics is a rapidly growing field, with new developments in imaging technology and radiopharmaceuticals allowing for more accurate diagnosis and treatment of diseases.
Some companies in the Radiopharmaceutical Theranostics market include GE Healthcare, Siemens Healthineers, Mallinckrodt Pharmaceuticals, and Bracco Diagnostics. Show Less   Read more